Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015, Article ID 536041, 7 pages
http://dx.doi.org/10.1155/2015/536041
Research Article

Association of Angiotensin Converting Enzyme Insertion-Deletion Polymorphism with Hypertension in Emiratis with Type 2 Diabetes Mellitus and Its Interaction with Obesity Status

1Department of Biomedical Engineering, Khalifa University of Science, Technology & Research, P.O. Box 127788, Abu Dhabi, UAE
2Dubai Diabetes Centre, Dubai Health Authority, Dubai, UAE
3School of Life Sciences, Manipal University, P.O. Box 345050, Dubai, UAE
4Immunology Clinics, Mafraq Hospital, Abu Dhabi, UAE
5Landmark Nephrology and Hypertension Clinic, Talladega, AL, USA

Received 17 June 2015; Accepted 12 August 2015

Academic Editor: Fabrizia Bamonti

Copyright © 2015 Habiba Alsafar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. C. N. Chan and C. S. Cockram, “Diabetes in the Chinese population and its implications for health care,” Diabetes Care, vol. 20, no. 11, pp. 1785–1790, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. G. N. Thomas, R. P. Young, B. Tomlinson et al., “A sibling-pair analysis of fasting lipids and anthropometric measurements and their relationship to hypertension,” Clinical and Experimental Hypertension, vol. 21, no. 7, pp. 1161–1176, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. S. E. Flores-Martínez, S. Islas-Andrade, M. V. MacHorro-Lazo et al., “DNA polymorphism analysis of candidate genes for type 2 diabetes mellitus in a Mexican ethnic group,” Annales de Genetique, vol. 47, no. 4, pp. 339–348, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Radha and V. Mohan, “Genetic predisposition of type 2 diabetes among Asian Indians,” Indian Journal of Medical Research, vol. 125, no. 3, pp. 259–274, 2007. View at Google Scholar · View at Scopus
  5. S. C. Elbein, “The genetics of human noninsulin-dependent (type 2) diabetes mellitus,” Journal of Nutrition, vol. 127, no. 9, pp. 1891S–1896S, 1997. View at Google Scholar · View at Scopus
  6. M. Ichikawa, T. Konoshita, T. Nakaya et al., “Genetic variant of the renin-angiotensin system and prevalence of type 2 diabetes mellitus: a modest but significant effect of aldosterone synthase,” Acta Diabetologica, vol. 51, no. 4, pp. 595–599, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Shaikh, S. M. Shahid, Q. Mansoor, M. Ismail, and A. Azhar, “Genetic variants of ACE (insertion/deletion) and AGT (M268T) genes in patients with diabetes and nephropathy,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 15, no. 2, pp. 124–130, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Al-Rubeaan, K. Siddiqui, A. T. M. Saeb, N. Nazir, D. Al-Naqeb, and S. Al-Qasim, “ACE I/D and MTHFR C677T polymorphisms are significantly associated with type 2 diabetes in Arab ethnicity: a meta-analysis,” Gene, vol. 520, no. 2, pp. 166–177, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Colussi, C. Catena, R. Lapenna, E. Nadalini, A. Chiuch, and L. A. Sechi, “Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients,” Diabetes Care, vol. 30, no. 9, pp. 2349–2354, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S. I. McFarlane and J. R. Sowers, “Aldosterone function in diabetes mellitus: effects on cardiovascular and renal disease,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 2, pp. 516–523, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Rigat, C. Hubert, P. Corvol, and F. Soubrier, “PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1),” Nucleic Acids Research, vol. 20, no. 6, article 1433, 1992. View at Google Scholar · View at Scopus
  12. L. Tiret, A. Bonnardeaux, O. Poirier et al., “Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction,” The Lancet, vol. 344, no. 8927, pp. 910–913, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Nitiyanant, S. Sriussadaporn, S. Ploybutr, P. Watanakejorn, M. Tunlakit, and S. Bejrachandra, “Angiotensin converting enzyme gene polymorphism in healthy Thais and patients with non-insulin dependent diabetes mellitus,” Journal of the Medical Association of Thailand, vol. 80, no. 12, pp. 747–752, 1997. View at Google Scholar · View at Scopus
  14. J. J. Jayapalan, S. Muniandy, and S. P. Chan, “Angiotensin-1 converting enzyme I/D gene polymorphism: scenario in Malaysia,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 39, no. 5, pp. 917–921, 2008. View at Google Scholar · View at Scopus
  15. R. A. Bayoumi, M. Simsek, T. M. Yahya et al., “Insertion-deletion polymorphism in the angiotensin-converting enzyme (ACE) gene among Sudanese, Somalis, Emiratis, and Omanis,” Human Biology, vol. 78, no. 1, pp. 103–108, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Baroudi, R. Bouhaha, C. Moran-Moguel et al., “Association of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene with type 2 diabetes in two ethnic groups of Jerba Island in Tunisia,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 10, no. 1, pp. 35–40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. V. V. S. Naresh, A. L. K. Reddy, G. Sivaramakrishna, P. V. G. K. Sharma, R. V. Vardhan, and V. Siva Kumar, “Angiotensin converting enzyme gene polymorphism in type II diabetics with nephropathy,” Indian Journal of Nephrology, vol. 19, no. 4, pp. 145–148, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Nikzamir, M. Nakhjavani, T. Golmohamadi, and L. Dibai, “Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with metabolic syndrome in Iranians with type 2 diabetes mellitus,” Archives of Iranian Medicine, vol. 11, no. 1, pp. 3–9, 2008. View at Google Scholar · View at Scopus
  19. H. Sinorita, M. Madiyan, R. B. Pramono, L. B. Purnama, M. R. Ikhsan, and A. H. Asdie, “ACE gene insertion/deletion polymorphism among patients with type 2 diabetes, and its relationship with metabolic syndrome at Sardjito Hospital Yogyakarta, Indonesia,” Acta Medica Indonesiana, vol. 42, no. 1, pp. 12–16, 2010. View at Google Scholar · View at Scopus
  20. J. J. Jayapalan, S. Muniandy, and S. P. Chan, “Null association between ACE gene I/D polymorphism and diabetic nephropathy among multiethnic Malaysian subjects,” Indian Journal of Human Genetics, vol. 16, pp. 78–86, 2010. View at Google Scholar
  21. V. Ramachandran, P. Ismail, J. Stanslas, and N. Shamsudin, “Analysis of renin-angiotensin aldosterone system gene polymorphisms in malaysian essential hypertensive and type 2 diabetic subjects,” Cardiovascular Diabetology, vol. 8, article 11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Morise, Y. Takeuchi, and R. Takeda, “Angiotensin-converting enzyme polymorphism and essential hypertension,” The Lancet, vol. 343, no. 8889, pp. 125–130, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. F.-T. Chiang, Z.-P. Lai, T.-H. Chern et al., “Lack of association of the angiotensin converting enzyme gene polymorphism with essential hypertension in a Chinese population,” American Journal of Hypertension, vol. 10, no. 2, pp. 197–201, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Cauchi, K. T. Nead, H. Choquet et al., “The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies,” BMC Medical Genetics, vol. 9, article 45, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Fujii, H. Ohnishi, S. Saitoh, H. Akasaka, T. Miura, and M. Mori, “The combination of abdominal obesity and high-sensitivity C-reactive protein predicts new-onset hypertension in the general Japanese population: the Tanno-Sobetsu study,” Hypertension Research, vol. 38, no. 6, pp. 426–432, 2015. View at Publisher · View at Google Scholar
  26. M. C. Y. Ng, K. S. Park, B. Oh et al., “Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians,” Diabetes, vol. 57, no. 8, pp. 2226–2233, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Scheffold, S. Kullmann, A. Huge et al., “Six sequence variants on chromosome 9p21.3 are associated with a positive family history of myocardial infarction: a multicenter registry,” BMC Cardiovascular Disorders, vol. 11, article 9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Vaxillaire, J. Veslot, C. Dina et al., “Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study,” Diabetes, vol. 57, no. 1, pp. 244–254, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. R. J. Neuman, J. Wasson, G. Atzmon et al., “Gene-gene interactions lead to higher risk for development of type 2 diabetes in an Ashkenazi Jewish population,” PLoS ONE, vol. 5, no. 3, Article ID e9903, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Wu, H. X. Li, R. J. F. Loos et al., “Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population,” Diabetes, vol. 57, no. 10, pp. 2834–2842, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Al-Safar, S. S. Pillai, L. J. Abood et al., “Interaction between angiotensin converting enzyme (ACE) insertion/deletion and aldosterone synthase (CYP11B2) -344C/T polymorphisms in relation to type 2 diabetes mellitus risk in Emiratis,” International Journal of Genetics and Molecular Biology, vol. 5, no. 2, pp. 20–27, 2013. View at Publisher · View at Google Scholar
  32. K. G. M. M. Alberti and P. Z. Zimmet, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, no. 7, pp. 539–553, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. P. A. James, S. Oparil, and B. L. Carter, “2014 evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the eighth joint national committee (JNC 8),” JAMA: The Journal of the American Medical Association, vol. 311, no. 5, pp. 507–520, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Lovati, A. Richard, B. M. Frey, F. J. Frey, and P. Ferrari, “Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease,” Kidney International, vol. 60, no. 1, pp. 46–54, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Ferrannini, G. Seghieri, and E. Muscelli, “Insulin and the renin-angiotensin-aldosterone system: influence of ACE inhibition,” Journal of Cardiovascular Pharmacology, vol. 24, supplement 3, pp. S61–S69, 1994. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Ambrosioni, S. Bacchelli, D. D. Esposti, and C. Borghi, “ACE-inhibitors and atherosclerosis,” European Journal of Epidemiology, vol. 8, no. 1, pp. 129–133, 1992. View at Publisher · View at Google Scholar · View at Scopus
  37. M. M. I. Hennes, I. M. O'Shaughnessy, T. M. Kelly, P. LaBelle, B. M. Egan, and A. H. Kissebah, “Insulin-resistant lipolysis in abdominally obese hypertensive individuals: role of the renin-angiotensin system,” Hypertension, vol. 28, no. 1, pp. 120–126, 1996. View at Publisher · View at Google Scholar · View at Scopus
  38. A. H. Salem and M. A. Batzer, “High frequency of the D allele of the angiotensin-converting enzyme gene in Arabic populations,” BMC Research Notes, vol. 2, article 99, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. S. S. Deeb, L. Fajas, M. Nemoto et al., “A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity,” Nature Genetics, vol. 20, no. 3, pp. 284–287, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Yamauchi, J. Kamon, H. Waki et al., “The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity,” Nature Medicine, vol. 7, no. 8, pp. 941–946, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. B. A. Maddux and I. D. Goldfine, “Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit,” Diabetes, vol. 49, no. 1, pp. 13–19, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. S. E. Kahn, R. L. Hull, and K. M. Utzschneider, “Mechanisms linking obesity to insulin resistance and type 2 diabetes,” Nature, vol. 444, no. 7121, pp. 840–846, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. G. N. Thomas, B. Tomlinson, J. C. N. Chan, J. E. Sanderson, C. S. Cockram, and J. A. J. H. Critchley, “Renin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese,” Diabetes Care, vol. 24, pp. 356–361, 2001. View at Google Scholar